Company Updates
Dentsply GSK unveils Haleon business generating annual sales of plc (GSK) has Sirona partners GlaxoSmithKline approximately £10bn. announced that the new company, to result from the proposed demerger As a standalone company, Haleon will of its Consumer Healthcare division in with FDI and be a new world-leader in consumer mid-2022, will be called Haleon. healthcare, offering a compelling proposition – to bring deep human Haleon (pronounced “Hay-Lee-On”) is Smile Train understanding together with trusted inspired by the merging of the words Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, has announced a three-way partnership with FDI World Dental Federation (FDI) and Smile Train, the world’s largest cleft-focused organization, to develop global standard protocols for digital cleft treatment that will increase access to digital treatments for patients with clefts and advance cleft care for the one in 700 babies born with cleft lip and/or palate around the globe.
The three partners will jointly work on integrating digital workflows and sustainable solutions into these new protocols as well as creating and providing the necessary clinical education infrastructure to oral health professionals around the world. The unique partnership also includes designing and setting up online courses and webinars to introduce dental professionals around the world to digital cleft care. Prior to this new partnership, Dentsply Sirona pledged a five-million-dollar donation to Smile Train as part of a five-year commitment to help children around the world gain access to cleft treatment, offering them the chance to live full and healthy lives.
‘Hale’, which is an old English word that means ‘in good health’ and Leon, which is associated with the word ‘strength’. The new brand identity was developed with input from employees, healthcare practitioners and consumers and will be deployed in more than 100 markets around the world where the business operates. The creation of Haleon results from a series of successful investments and strategic changes to GSK’s consumer health business over the last eight years, including integrations of the consumer product portfolios from Novartis and Pfizer. It is now a highly valuable and focused global
science – to deliver better everyday health with humanity.
Brian McNamara, chief executive officer designate, Haleon, said, “Introducing Haleon to the world marks another step in our journey to become a new, standalone company. Our name is grounded in our purpose to deliver better everyday health with humanity and to be a world-leader in consumer healthcare. We are on track to launch Haleon in mid-2022 and our business momentum is strong.”
Dentists’ Provident appoints new board member Dentists’ Provident, income protection provider for the dental industry, has appointed Matt Payne to its board. As the new executive director at Dentists’ Provident, Matt Payne will strengthen the company’s executive team with operational oversight of the information systems team.
individual members at the centre of all they do. I’m looking forward to getting to know the business even more over the coming months and help move Dentists’ Provident forward,” says Matt.
Matt is a graduate in computer sciences and holds an MBA from Cardiff Business School. He has over 25 years’ experience in information technology development, operations and management, including senior leadership roles in financial services and software industries in the UK, US and EMEA. “We are very excited about Matt joining the Dentists’ Provident Board. Like so many businesses, we are hugely dependent on technology, and we really wanted to further strengthen this area of our business. Matt brings a wealth of national and international experience and has made a great impact already,” says Farrukh Mirza, CEO of Dentists’ Provident. “In my short time at Dentists’ Provident, I’ve been really impressed with the ethos of truly putting the
8
Issue 1 2022
pg8-11 Company News.indd 8
DentalInsider 21/04/2022 10:04